HSBC Holdings’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-15,890
| Closed | -$105K | – | 2380 |
|
|
2020
Q4 | $105K | Buy |
15,890
+3,954
| +33% | +$26.1K | ﹤0.01% | 2489 |
|
|
2020
Q3 | $80K | Sell |
11,936
-1,899
| -14% | -$12.7K | ﹤0.01% | 2195 |
|
|
2020
Q2 | $115K | Sell |
13,835
-683
| -5% | -$5.68K | ﹤0.01% | 2112 |
|
|
2020
Q1 | $111K | Buy |
14,518
+2,582
| +22% | +$19.7K | ﹤0.01% | 2040 |
|
|
2019
Q4 | $99K | Sell |
11,936
-1,596
| -12% | -$13.2K | ﹤0.01% | 2379 |
|
|
2019
Q3 | $100K | Buy |
+13,532
| New | +$100K | ﹤0.01% | 2374 |
|
|
2018
Q3 | – | Sell |
-9,718
| Closed | -$222K | – | 1927 |
|
|
2018
Q2 | $222K | Buy |
+9,718
| New | +$222K | ﹤0.01% | 1835 |
|